NCT02474368View on ClinicalTrials.gov

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2021

Study Completion Date

June 30, 2026

Conditions
Recurrent Head and Neck CarcinomaHead and Neck Cancer MetastaticHead or Neck Cancer
Interventions
RADIATION

Intensity Modulated Radiation Therapy (IMRT)

DRUG

Cisplatin

RADIATION

Stereotactic Body Radiotherapy (SBRT)

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER